ATE399322T1 - Chemische verbindung und test - Google Patents

Chemische verbindung und test

Info

Publication number
ATE399322T1
ATE399322T1 AT04793802T AT04793802T ATE399322T1 AT E399322 T1 ATE399322 T1 AT E399322T1 AT 04793802 T AT04793802 T AT 04793802T AT 04793802 T AT04793802 T AT 04793802T AT E399322 T1 ATE399322 T1 AT E399322T1
Authority
AT
Austria
Prior art keywords
test
chemical compound
erg
ligand compound
compounds
Prior art date
Application number
AT04793802T
Other languages
English (en)
Inventor
Brian Springthorpe
Gert Strandlund
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE399322T1 publication Critical patent/ATE399322T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Materials For Medical Uses (AREA)
AT04793802T 2003-10-20 2004-10-18 Chemische verbindung und test ATE399322T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0302775A SE0302775D0 (sv) 2003-10-20 2003-10-20 Chemical compound and assay

Publications (1)

Publication Number Publication Date
ATE399322T1 true ATE399322T1 (de) 2008-07-15

Family

ID=29546593

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04793802T ATE399322T1 (de) 2003-10-20 2004-10-18 Chemische verbindung und test

Country Status (11)

Country Link
US (1) US20070048215A1 (de)
EP (1) EP1678499B1 (de)
JP (1) JP2007513874A (de)
CN (1) CN1871516A (de)
AT (1) ATE399322T1 (de)
DE (1) DE602004014633D1 (de)
ES (1) ES2307058T3 (de)
HK (1) HK1089233A1 (de)
SE (1) SE0302775D0 (de)
TW (1) TW200526255A (de)
WO (1) WO2005037052A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080037655A (ko) 2005-07-21 2008-04-30 아스트라제네카 아베 신규 피페리딘 유도체

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2428792A1 (de) * 1974-06-14 1976-01-02 Knoll Ag Neue antiarrhythmika
DE3234697A1 (de) * 1982-09-18 1984-03-22 Kali-Chemie Pharma Gmbh, 3000 Hannover Neue diazabicyclo-(3,3,1)-nonane
DE3730224A1 (de) * 1987-09-09 1989-03-23 Kali Chemie Pharma Gmbh 3-cinnamyl-3,7-diazabicyclo(3,3,1) nonan-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3732094A1 (de) * 1987-09-24 1989-04-06 Basf Ag Bispidinderivate als klasse iii-antiarrhythmika
AR030302A1 (es) * 2000-07-07 2003-08-20 Astrazeneca Ab Compuestos de bispidina, formulacion farmaceutica, uso para la fabricacion de medicamentos, proceso para la preparacion de estos compuestos y compuestos intermediarios
AU2001277863A1 (en) * 2000-07-14 2002-01-30 Merck And Co., Inc. Radioligand and binding assay
DK1410019T3 (da) * 2001-07-13 2006-03-06 Janssen Pharmaceutica Nv Assay for kardiovaskulær sikkerhed
EP1423700A2 (de) * 2001-09-04 2004-06-02 Pfizer Limited Affinitätsassay für den humanen erg kaliumkanal

Also Published As

Publication number Publication date
SE0302775D0 (sv) 2003-10-20
EP1678499A2 (de) 2006-07-12
EP1678499B1 (de) 2008-06-25
JP2007513874A (ja) 2007-05-31
CN1871516A (zh) 2006-11-29
WO2005037052A3 (en) 2005-07-07
ES2307058T3 (es) 2008-11-16
US20070048215A1 (en) 2007-03-01
TW200526255A (en) 2005-08-16
HK1089233A1 (en) 2006-11-24
WO2005037052A2 (en) 2005-04-28
DE602004014633D1 (de) 2008-08-07

Similar Documents

Publication Publication Date Title
EA200200530A1 (ru) Гетероциклические замещенные пиразолоны
ATE483825T1 (de) Zusammensetzungen für die identifizierung von adenoviren
EA200801063A1 (ru) Диароматические амины
DE502005002227D1 (de) Lanthanoidchelate und ihre anwendung in der bioanalytik
ATE338565T1 (de) Verwendung eines antagonisten antikörpers gegen den entzündungsmediator oncostatin m (osm)
PL369530A1 (en) Chemical compounds
DK1316801T3 (da) Sammensætninger og fremgangsmåder til detektion og behandling af sygdomme og tilstande, som er relateret til kemokinreceptorer
TR199900090A2 (xx) Benzos�lfon t�revleri
WO2004074812A3 (en) Library of biphenyl derivatives useful for identifying compounds having both beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
ATE415631T1 (de) AFFINITÄTSSCREENING MITTELS BIBLIOTHEKEN DES TYPS ßEINE-VERBINDUNG-PRO-KÜGELCHENß
ATE424560T1 (de) Marker für neuromyelitis optica
DE602006008639D1 (de) Automatisches radioaktives markierungsverafhren
IL200120A0 (en) Compositions, reagents and kits for and methods of diagnosing, monitoring and treating obesity and/or diabetes
EA200301100A1 (ru) Новые фталазиноны
DE60322019D1 (de) Kaliumkanal-modulatoren
BR0317229A (pt) Composição e uso de agonista completo de alfa7nachr
HRP20050607B1 (hr) Supstituirani benzizoksazol sulfonamid hiv proteazni inhibitori širokog spektra
WO2005000875A3 (en) Compositions and methods comprising a ligand of chemerin receptor
DE69905273D1 (de) Verfahren und zusammensetzung zur inhibierung der polymerisierung von ethylenisch ungesättigten kohlenwasserstoffen
ATE399322T1 (de) Chemische verbindung und test
EA200000910A1 (ru) Азабициклические лиганды рецепторов 5нт1
ES2163009T3 (es) Procedimiento para el analisis de polvo domestico.
WO2006017748A3 (en) Materials and methods for identifying anti-schizophrenic agents
EP1521843A4 (de) Chemilumineszenz-nachweisverfahren
EA200500125A1 (ru) СПОСОБ ОБОГАЩЕНИЯ И ОБНАРУЖЕНИЯ ПАТОЛОГИЧЕСКИ ИЗМЕНЕННЫХ ПРИОНПРОТЕИНОВ (PrP)

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties